A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

dc.contributor.authors	Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators.
dc.date.accessioned	2020-02-27T08:33:38Z
dc.date.available	2020-02-27T08:33:38Z
dc.date.issued	2003
dc.identifier.citation	Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators. (2003). A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.. JAMA, 390, 2816-2805
dc.identifier.issn	0098-7484
dc.identifier.uri	https://doi.org/10.1001/jama.290.21.2805
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66401
dc.title	A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
dc.identifier.volume	390
dc.identifier.startpage	2805
dc.identifier.endpage	2816
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Akdemir, Ramazan
dc.relation.journal	JAMA
dc.identifier.wos	SAU
dc.identifier.doi	10.1001/jama.290.21.2805
dc.contributor.author	Akdemir, Ramazan